Webinar: An Update on Lecanemab for Early Stage Alzheimer’s Disease
September 26, 2024, 12pm to 1pm
Patients, families, and the wider community are invited to talk about the current amyloid-clearing infusion medications Leqembi (lecanemab) and Kisunla (donanemab) for the treatment of Alzheimer's. Come learn from our panel of experts which include, Dr. Thomas Grabowski, Dr. Michael Rosenbloom and clinical trials coordinator Darla Chapman, ARNP.
• Who is eligible for these treatments?
• What are the risks and benefits?
• What is the process if you're interested in these medications?
• What is the impact of these medications as well as similar ones in the pipeline for the clinic community and research?
• How has it been going for those patients who have been given the Leqembi infusion?
Location: Zoom
Upcoming Events in Community Talks and Outreach
-
UW Alzheimer's Research Update by Michael Rosenbloom, MD
Wednesday, September 25, 2024 at 2:00pm
Please join us for an afternoon presentation led by Dr. Rosenbloom about current research studies at the UW ADRC and how to become involved, hosted by the UW ADRC and Greenwood Senior Center.
-
Community Webinar: An Update on Lecanemab for Early Stage Alzheimer’s Disease
Thursday, September 26, 2024 at 12:00pm
Patients, families, and the wider community are invited to talk about the current amyloid-clearing infusion medications Leqembi (lecanemab) and Kisunla (donanemab) for the treatment of Alzheimer's. Come learn from our panel of experts which include, Dr. Thomas Grabowski, Dr. Michael Rosenbloom and clinical trials coordinator Darla Chapman, ARNP.